Literature DB >> 10660512

Antibiotic use in Dutch hospitals 1991-1996.

R Janknegt1, A Oude Lashof, I M Gould, J W van der Meer.   

Abstract

The use of antibiotics in Dutch hospitals between 1991 and 1996 was investigated. A total of 54 hospitals responded to the enquiry, representing over 70% of all hospital beds in The Netherlands. The use of antibiotics in Dutch hospitals, expressed as defined daily doses (DDD) per hundred bed days, gradually increased from 37.2 DDD per 100 bed days in 1991 to 42.5 DDD per 100 bed days in 1996. The antibiotic that showed the largest increase in use was co-amoxiclav. Its use increased more than three-fold from 3.93 DDD per 100 bed days in 1991 to 12.5 DDD per 100 bed days in 1996. The increase in use of co-amoxiclav exceeded the increase in total antibiotic consumption. The use of cephalosporins remained fairly constant during the study period, but there were changes in the relative use of the different cephalosporin groups. The use of earlier cephalosporins gradually decreased, whereas the use of the more recently developed cephalosporins increased between 1991 and 1996. Ciprofloxacin and norfloxacin were the most commonly used fluoroquinolones throughout the study period. The use of ofloxacin increased significantly between 1991 and 1996, approaching the levels of use of ciprofloxacin and norfloxacin. There may be complex reasons for the increases, which need further analysis, but they mirror those few data available from elsewhere in the world. Possible explanations include more intensive treatment to expedite patient discharges, sicker patients with more serious infections and more resistant organisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660512     DOI: 10.1093/jac/45.2.251

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Antimicrobial utilization and bacterial resistance at three different hospitals.

Authors:  V Vlahović-Palcevski; M Morović; G Palcevski; L Betica-Radić
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Widespread dissemination in The Netherlands of the epidemic berlin methicillin-resistant Staphylococcus aureus clone with low-level resistance to oxacillin.

Authors:  W J B Wannet; E Spalburg; M E O C Heck; G N Pluister; R J L Willems; A J De Neeling
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

3.  Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital.

Authors:  Arno Muller; Dominique L Monnet; Daniel Talon; Thierry Hénon; Xavier Bertrand
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

4.  Complicated community-acquired soft tissue infection by MRSA from porcine origin.

Authors:  Ph Declercq; D Petré; B Gordts; A Voss
Journal:  Infection       Date:  2007-10-31       Impact factor: 3.553

5.  Relationship between Antimicrobial Consumption and the Incidence of Antimicrobial Resistance in Escherichia coli and Klebsiella pneumoniae Isolates.

Authors:  Noyal Mariya Joseph; B Bhanupriya; Deepak Gopal Shewade; Belgode Narasimha Harish
Journal:  J Clin Diagn Res       Date:  2015-02-01

6.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

7.  Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database.

Authors:  Wim G Goettsch; Rob Janknegt; Ron M C Herings
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

8.  Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Thgerapeutic Chemical classification and Definied Daily Dose system methodology in Canada.

Authors:  James M Hutchinson; David M Patrick; Fawziah Marra; Helen Ng; William R Bowie; Laurie Heule; Mark Muscat; Dominique L Monnet
Journal:  Can J Infect Dis       Date:  2004-01

9.  Prescription of Levofloxacin and Moxifloxacin in Select Hospitals in Uganda: A Pilot Study to Assess Guideline Concordance.

Authors:  Victoria Nambasa; Helen B Ndagije; Allan Serwanga; Leonard Manirakiza; Joanitah Atuhaire; Diana Nakitto; Ronald Kiguba; Albert Figueras
Journal:  Antibiotics (Basel)       Date:  2020-07-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.